Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/06/1999 | WO1998056930A9 Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
05/06/1999 | WO1998042860A9 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
05/06/1999 | EP0913692A1 An immunoassay for procollagen-III-C-terminal propeptide |
05/06/1999 | EP0913479A2 Adenine glycosylase |
05/06/1999 | EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993 |
05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
05/06/1999 | EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor |
05/06/1999 | EP0913470A2 The human C3b/C4b receptor (CR1) |
05/06/1999 | EP0913404A1 Differentiation inhibitor |
05/06/1999 | EP0912898A2 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg |
05/06/1999 | EP0912896A1 Screen for ultraspiracle inhibitors |
05/06/1999 | EP0912758A1 Compositions and methods for screening antimicrobials |
05/06/1999 | EP0912749A1 Suppression of specific classes of soybean seed protein genes |
05/06/1999 | EP0912747A1 Aspartic protease |
05/06/1999 | EP0912744A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
05/06/1999 | EP0912743A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
05/06/1999 | EP0912742A1 Viral interleukin-6 |
05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
05/06/1999 | EP0912740A1 Rantes homolog from prostate |
05/06/1999 | EP0912739A2 Canine ob protein compositions and methods |
05/06/1999 | EP0912737A1 Human osteoclast-specific and -related dna sequences |
05/06/1999 | EP0912736A1 A lysosomal-associated multispanning membrane protein, laptm5 and a nucleic acid encoding laptm5 |
05/06/1999 | EP0912735A2 Secreted proteins and polynucleotides encoding them |
05/06/1999 | EP0912734A1 Chimeric heteromultimer adhesins |
05/06/1999 | EP0912733A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
05/06/1999 | EP0912732A1 Gamma ii adaptin |
05/06/1999 | EP0912731A2 Secreted proteins |
05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
05/06/1999 | EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces |
05/06/1999 | EP0912727A1 Reagent to increase the specificity of inhibition of serine proteases |
05/06/1999 | EP0912726A1 Methods for oxidizing disulfide bonds using ozone |
05/06/1999 | EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
05/06/1999 | EP0912610A1 A novel galanin receptor |
05/06/1999 | EP0912609A2 Fragments of leptin (ob protein) |
05/06/1999 | EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines |
05/06/1999 | EP0912607A2 Vaccines comprising synthetic genes |
05/06/1999 | EP0912606A2 Secreted proteins and polynucleotides encoding them |
05/06/1999 | EP0912605A1 Imprint polypeptides covalently cross-linked and having a fixed and stabilised arrangement, process for the preparation and use thereof |
05/06/1999 | EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh |
05/06/1999 | EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
05/06/1999 | EP0912596A1 Plant plastid division genes |
05/06/1999 | EP0912595A1 Hodgkin's disease associated molecules and uses thereof |
05/06/1999 | EP0912594A1 Identification of essential survival genes |
05/06/1999 | EP0912197A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
05/06/1999 | EP0912195A1 Vaccine comprising antigens bound to carriers through labile bonds |
05/06/1999 | EP0912194A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
05/06/1999 | EP0912193A1 Vaccine to prevent streptococcal endocarditis |
05/06/1999 | EP0912157A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
05/06/1999 | EP0912096A2 Plant protection method |
05/06/1999 | EP0787299A4 Receptor for a bacillus thuringiensis toxin |
05/06/1999 | EP0785792B1 Treatment of ovarian estrogen dependent conditions |
05/06/1999 | EP0746333B1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
05/06/1999 | EP0688327B1 Analogs for specific oligosaccharide-protein interactions and uses therefor |
05/06/1999 | EP0624199B1 Methods for producing thrombin |
05/06/1999 | EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
05/06/1999 | EP0576439B1 Monoclonal antibody against lps core |
05/06/1999 | EP0541692B1 Herpes simplex virus vp16 vaccines |
05/06/1999 | DE19748734A1 Preparing active growth factor dimers from inclusion bodies in high yield |
05/06/1999 | CA2712809A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
05/06/1999 | CA2308705A1 Aggregates of human insulin derivatives |
05/06/1999 | CA2308548A1 P-40/annexin i and related proteins and their role in multidrug resistance |
05/06/1999 | CA2308463A1 Cd8 as an inhibitor of the cellular immune system |
05/06/1999 | CA2308115A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
05/06/1999 | CA2308102A1 New nucleotide sequences |
05/06/1999 | CA2308014A1 Dna encoding a human proton-gated ion channel and uses thereof |
05/06/1999 | CA2307953A1 Gene therapy for stimulation of angiogenesis |
05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
05/06/1999 | CA2307716A1 Reagents and methods useful for detecting diseases of the breast |
05/06/1999 | CA2307320A1 148 human secreted proteins |
05/06/1999 | CA2307196A1 Non-transgenic animal model of alzheimer's disease |
05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |
05/06/1999 | CA2307171A1 A novel mitogenic cyclin and uses thereof |
05/06/1999 | CA2307017A1 Erythropoietin-mediated neurogenesis |
05/06/1999 | CA2307014A1 Viral encoded semaphorin protein receptor dna and polypeptides |
05/06/1999 | CA2306905A1 Fatty acid-acylated insulin analogs |
05/06/1999 | CA2306877A1 Insoluble insulin compositions |
05/06/1999 | CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
05/06/1999 | CA2305631A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
05/06/1999 | CA2304984A1 Binary viral expression system in plants |
05/05/1999 | CN1216065A Export systems for recombinant proteins |
05/05/1999 | CN1216064A Synthetic HIV genes |
05/05/1999 | CN1216063A IL-6 mutein |
05/05/1999 | CN1216047A Antifungic and antibaterial peptide |
05/05/1999 | CN1215755A Method of introducing predetermined alteration in target sequence of genome of cell having nucleus |
05/05/1999 | CN1215729A Clostridium perfringens vaccine |
05/04/1999 | US5900480 cDNA encoding a polypeptide including a hevein sequence |
05/04/1999 | US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents |
05/04/1999 | US5900405 Polymers responsive to electrical energy |
05/04/1999 | US5900404 Chemical modification of proteins to improve biocompatibility and bioactivity |
05/04/1999 | US5900401 Remedy for respiratory-tract viral disease |
05/04/1999 | US5900400 Protein |
05/04/1999 | US5900371 Zinc chelate enzyme inhibitor |
05/04/1999 | US5900237 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
05/04/1999 | CA2248171A1 Improvements in or relating to detection of salmonella |
05/04/1999 | CA2129637C Treatment for inflammatory bowel disease |
05/04/1999 | CA2037333C Dna encoding a major mite allergen and the use thereof |
05/04/1999 | CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
05/04/1999 | CA1340526C Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment |
05/04/1999 | CA1340525C Immunoassay for the detection of a-haloacetamides |